Metrorrhagia
Showing 601 - 625 of 642
Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Fingolimod 1.25 mg, Fingolimod 0.5 mg, Placebo)
Completed
- Relapsing-remitting Multiple Sclerosis
- Fingolimod 1.25 mg
- +2 more
-
Woodville South, South Australia, Australia
- +114 more
Apr 9, 2012
Depression - MDD Trial in Bruxelles (desvenlafaxine succinate sustained release)
Completed
- Depression - Major Depressive Disorder
- desvenlafaxine succinate sustained release
-
Bruxelles, BelgiumPfizer Investigational Site
Dec 21, 2011
Age Related Macular Degeneration (AMD), Macular Degeneration, Choroidal Neovascularization (CNV) Trial in Worldwide (Pegaptanib
Terminated
- Age Related Macular Degeneration (AMD)
- +2 more
- Pegaptanib Sodium 0.3 mg
-
Graz, Austria
- +57 more
Apr 2, 2012
Carcinoma, Pancreatic Ductal Trial in Worldwide (AG-013736, Gemcitabine, )
Rheumatoid Arthritis Trial in Worldwide (adalimumab, methotrexate, )
Completed
- Rheumatoid Arthritis
- adalimumab
- +2 more
-
Birmingham, Alabama
- +169 more
Apr 16, 2012
Methicillin Resistant Staphylococcus Aureus (MRSA) Trial in Worldwide (linezolid (Zyvox), vancomycin)
Completed
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- linezolid (Zyvox)
- vancomycin
-
Birmingham, Alabama
- +176 more
Jan 30, 2012
Rheumatoid Arthritis Trial in United States (Double-blind Abatacept, Double-blind Placebo, Open-label Abatacept)
Completed
- Rheumatoid Arthritis
- Double-blind Abatacept
- +2 more
-
Decatur, Alabama
- +43 more
Nov 15, 2011
Pemphigus Vulgaris (PV) Trial in Worldwide (Mycophenolate Mofetil 2 g/Day, Mycophenolate Mofetil (MMF) 3 g/Day, Placebo)
Completed
- Pemphigus Vulgaris (PV)
- Mycophenolate Mofetil 2 g/Day
- +2 more
-
Los Angeles, California
- +25 more
May 25, 2011
Transplantation Infection Trial (Everolimus 0.25 and 0.75 mg tablets, Cyclosporine very low dose (150-300 ng/mL) microemulsion,
Completed
- Transplantation Infection
- Everolimus 0.25 and 0.75 mg tablets
- +2 more
- (no location specified)
May 17, 2011
Human Immunodeficiency Virus Infections Trial in Abbott Park (lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide
Completed
- Human Immunodeficiency Virus Infections
- lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
-
Abbott Park, IllinoisMedical Information - Abbott (1-800-633-9110)
Apr 7, 2011
Rheumatoid Arthritis Trial in United States (Abatacept, Placebo)
Rheumatoid Arthritis Trial in United States (Abatacept, Methotrexate, Placebo)
Depressive Disorder, Major Trial (desvenlafaxine succinate sustained release, Genotyping)
Completed
- Depressive Disorder, Major
- desvenlafaxine succinate sustained release
- Genotyping
- (no location specified)
Mar 4, 2011
Vasomotor Symptoms Trial in Canada, United States (desvenlafaxine succinate (DVS) SR, Placebo)
Completed
- Vasomotor Symptoms
- desvenlafaxine succinate (DVS) SR
- Placebo
-
Birmingham, Alabama
- +120 more
Jul 21, 2011
MDD Trial in Worldwide (Duloxetine Hydrochloride, Escitalopram)
Completed
- Major Depressive Disorder
- Duloxetine Hydrochloride
- Escitalopram
-
Copenhagen, Denmark
- +59 more
May 20, 2011
Breakthrough Bleeding, Breakthrough Spotting Trial in Temple (remove ring if bleeding or spotting occurs more than 5 days, If
Completed
- Breakthrough Bleeding
- Breakthrough Spotting
- remove ring if bleeding or spotting occurs more than 5 days
- If bleeding does not remove ring
-
Temple, TexasScott & White Hospital and Clinic
Dec 17, 2009
Healthy Trial in Fargo (Drospirenone/Ethinyl Estradiol (Gianvi®), YAZ®)
Completed
- Healthy
- Drospirenone/Ethinyl Estradiol (Gianvi®)
- YAZ®
-
Fargo, North DakotaPRACS Institute, Ltd.
Nov 22, 2010
MDD Trial in United States (Desvenlafaxine Succinate Sustained-Release 10mg, Desvenlafaxine Succinate Sustained-Release 50 mg, )
Completed
- Major Depressive Disorder
- Desvenlafaxine Succinate Sustained-Release 10mg
- +2 more
-
Birmingham, Alabama
- +23 more
Apr 7, 2011
Renal Failure Trial in Worldwide (10mg Rosuvastatin, Placebo)
Completed
- Renal Failure
- 10mg Rosuvastatin
- Placebo
-
St Leonards, New South Wales, Australia
- +240 more
May 17, 2011
Breast Tumors Trial (Letrozole / Temsirolimus (CCI-779), Letrozole)
Completed
- Breast Neoplasms
- Letrozole / Temsirolimus (CCI-779)
- Letrozole
- (no location specified)
Apr 13, 2011
Diabetes, Type 2 Trial in Investigative Site, Investigative Sites (Valsartan 160 mg + nateglinide 60 mg, Valsartan 160 mg +
Completed
- Diabetes Mellitus, Type 2
- Valsartan 160 mg + nateglinide 60 mg
- +3 more
-
Investigative Site, New Jersey
- +37 more
Jun 27, 2011